Pathological features of primary breast cancer in the elderly based on needle core biopsies-A large series from a single centre

Critical Reviews in Oncology/Hematology

Volumn 67, Issue 3, 2008, Pages 263-267

  Cheung, K L ^a   Wong, A W S ^a   Parker, H ^a   Li, V W Y ^a   Winterbottom, L ^b   Morgan, D A L ^b   Ellis, I O ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Breast cancer; Early primary breast cancer; Elderly; Needle core biopsy; Oestrogen receptor; Pathology

Indexed keywords

ESTROGEN RECEPTOR;

AGED; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; RECEPTOR DENSITY; REVIEW;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GREAT BRITAIN; HUMANS; MYOEPITHELIOMA; RECEPTORS, ESTROGEN;

EID: 48749129371     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.04.002     Document Type: Review

References (28)

1. Clark G., Osborne C., and McGuire W. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2 (1984) 1102-1109
2. Gruenberger T., Gorlitzer M., Soliman T., et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res. Treat 50 (1998) 37-46
3. Sader C., Ingram D., and Hastrich D. Management of breast cancer in the elderly by complete local excision and tamoxifen alone. Aust N Z J Surg 69 (1999) 790-793
4. McCready D., Chapman J., Hanna W., et al. Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal women. Ann Surg Oncol 7 (2000) 562-567
5. de Csepel J., Tartter P., and Gajdos C. When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol 74 (2000) 273-277
6. Bartelink H., Horiot J., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
7. Valassiadou K., Morgan D., Robertson J., Pinder S., and Cheung K. Successful management of elderly breast cancer patients treated without radiotherapy. World J Surg Oncol 5 (2007) 62
8. Hughes K., Schnaper L., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
9. Benhaim D., Lopchinsky R., and Tartter P. Lumpectomy with tamoxifen as primary treatment for elderly women with early-stage breast cancer. Am J Surg 180 (2000) 162-166
10. Group EBCTC. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
11. Elston C., and Ellis I. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
12. NHSBSP, RCPath. Pathology reporting of breast disease. A Joint Document Incorporating the Third Edition of the NHS Breast Screening Programme's Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists' Minimum Dataset for Breast Cancer Histopathology. NHSBSP Publication No 58; 2005.
13. Howell A., Barnes D., Harland R., et al. Steroid-hormone receptors in survival after first relapse in breast cancer. Lancet 1 (1984) 588-591
14. Sharifi S., Peterson M., Baum J., Raza S., and Schnitt S. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 13 (1999) 1332-1333
15. Badoual C., Maruani A., Ghorra C., Lebas P., Avigdor S., and Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. Breast 14 (2005) 22-27
16. Harris G., Denley H., Pinder S., et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 27 (2003) 11-15
17. Jacobs T., Siziopikou K., Prioleau J., et al. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?. Mod Pathol 11 (1998) 259-264
18. Hodi Z., Chakrabarti J., Lee A., et al. The reliability of assessment of oestrogen receptor expression on needle core biopsies of invasive carcinomas of the breast. J Clin Pathol 60 (2007) 299-302
19. Dillon M., Quinn C., McDermott E., O'Doherty A., O'Higgins N., and Hill A. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice. J Clin Pathol 59 (2006) 740-743
20. Abd El-Rehim D., Ball G., Pinder S., et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression anal International. J Cancer 116 (2005) 340-350
21. Crivellari D., Aapro M., Leonard R., et al. Breast cancer in the elderly. J Clin Oncol 25 14 (2007) 1882-1890
22. Daidone M.G., Coradini D., Martelli G., and Veneroni S. Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol-Hematol 45 3 (2003) 313-325
23. Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer.[see comment]. J National Cancer Inst 92 7 (2000) 550-556
24. Molino A., Giovannini M., Auriemma A., et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol-Hematol 59 3 (2006) 226-233
25. Hind D., Wyld L., Beverley C.B., and Reed M.W. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev 1 (2006) CD004272
26. Ying M, Agrawal A, Winterbottom L, Morgan D, Ellis I, Cheung K. Anastrozole versus tamoxifen as primary endocrine therapy for early operable primary breast cancer in the elderly. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25:18S:11025.
27. Smith I.E., Dowsett M., Ebbs S.R., et al. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the immediate preoperative anastrozole, tamoxifen, or combined with tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 23 22 (2005) 5108-5116
28. Ellis M.J., Coop A., Singh B., et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.[see comment]. J Clin Oncol 19 18 (2001) 3808-3816